Trial · NCT00940342
Adverse events54
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 54
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Injection Site Reaction | Skin and subcutaneous tissue disorders | Treated and Relapsed - Group 1 | 6 | 50 | 6 |
| other | Injection Site Reaction | Skin and subcutaneous tissue disorders | Untreated and High-Risk for Progression - Group 2 | 10 | 40 | 10 |
| other | Injection Site Reaction | Skin and subcutaneous tissue disorders | 70 Years of Age and Refused Chemo - Group 3 | 10 | 40 | 10 |
| other | Pain | General disorders | Treated and Relapsed - Group 1 | 4 | 50 | 4 |
| other | Pain | General disorders | Untreated and High-Risk for Progression - Group 2 | 4 | 40 | 4 |
| other | Pain | General disorders | 70 Years of Age and Refused Chemo - Group 3 | 1 | 40 | 1 |
| other | Fever | General disorders | Treated and Relapsed - Group 1 | 3 | 50 | 3 |
| other | Fever | General disorders | Untreated and High-Risk for Progression - Group 2 | 1 | 40 | 1 |
| other | Fever | General disorders | 70 Years of Age and Refused Chemo - Group 3 | 1 | 40 | 1 |
| other | Chills | General disorders | Treated and Relapsed - Group 1 | 3 | 50 | 3 |
| other | Chills | General disorders | Untreated and High-Risk for Progression - Group 2 | 0 | 40 | 0 |
| other | Chills | General disorders | 70 Years of Age and Refused Chemo - Group 3 | 1 | 40 | 1 |
| other | Neutropenia | Infections and infestations | Treated and Relapsed - Group 1 | 11 | 50 | 11 |
| other | Neutropenia | Infections and infestations | Untreated and High-Risk for Progression - Group 2 | 4 | 40 | 4 |
| other | Neutropenia | Infections and infestations | 70 Years of Age and Refused Chemo - Group 3 | 6 | 40 | 6 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Treated and Relapsed - Group 1 | 3 | 50 | 3 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Untreated and High-Risk for Progression - Group 2 | 0 | 40 | 0 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | 70 Years of Age and Refused Chemo - Group 3 | 2 | 40 | 2 |
| other | Shortness of Breath | Respiratory, thoracic and mediastinal disorders | Treated and Relapsed - Group 1 | 0 | 50 | 0 |
| other | Shortness of Breath | Respiratory, thoracic and mediastinal disorders | Untreated and High-Risk for Progression - Group 2 | 0 | 40 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00940342/events